Kota C-section deaths: Drug supply chain probe begins, legal action under Drugs Act
Synopsis
One Oxytocin batch at GMC Kota has been declared spurious — but the hospital insists it cannot be blamed for five post-C-section deaths. With a drug supply chain probe underway and legal action initiated under the Drugs and Cosmetics Act, the case has exposed a fault line between media narratives and clinical evidence.
Key Takeaways
Five women died following C-section complications at Government Medical College Kota .
The Drug Control Department has collected 28 medicine samples ; results for 23 are in — all compliant except Oxytocin batch TOCIN I-7881 , declared 'Not of Standard Quality/Spurious' .
Legal proceedings have been initiated under the Drugs and Cosmetics Act, 1940 , which carries provisions for FIR and imprisonment.
GMC Kota states the deaths are linked to Sepsis and Multi-Organ Dysfunction Syndrome (MODS) , not conclusively to Oxytocin.
A drug supply chain investigation is underway; the Rajasthan government has promised strict action against any guilty party.
The Rajasthan government and the Drug Control Department have launched immediate action following the deaths of five women after cesarean section (C-section) complications at Government Medical College (GMC) Kota, officials confirmed on Tuesday, 26 May. Medicine samples collected from the hospital have been sent for laboratory testing, while a parallel investigation into the drug supply chain is now underway.
Legal Proceedings Initiated
Authorities have commenced legal proceedings under the Drugs and Cosmetics Act, 1940, which carries provisions for filing an FIR and imprisonment if guilt is established. GMC Kota Principal Dr Nilesh Jain confirmed the development, adding that the probe is intensifying across multiple fronts — from clinical records to procurement channels.
The Oxytocin Sample Finding
Of 28 medicine samples collected and dispatched — 23 to the State Drug Testing Laboratory, Jaipur and the remainder to national laboratories — results for 23 samples have been received so far. All but one passed prescribed quality standards. The sole exception is an Oxytocin injection with batch number TOCIN I-7881, which has been declared 'Not of Standard Quality/Spurious' after failing a specific test parameter.
However, GMC Kota has issued a formal clarification stating that this finding alone cannot be treated as conclusive proof that the injection caused the deaths. The institution said the conclusion linking Oxytocin to mortality is 'not scientifically proven', based on medical facts and expert review.
What Medical Records Show
According to Dr Jain, a review of medical records and expert analysis indicates the deceased women were suffering from severe conditions including Sepsis and Multi-Organ Dysfunction Syndrome (MODS). No clinical evidence has emerged to establish Oxytocin as the direct cause of death.
Medical experts further noted that emergency interventions — including ventilator support, antibiotics, and intravenous fluids — are routinely administered in such cases, and the use of Oxytocin in those circumstances does not automatically imply a causal link to mortality.
Government Assurance and Next Steps
The Rajasthan government has assured that the matter is being investigated thoroughly through scientific and laboratory analysis. Strict action, it stated, will be taken against any individual, institution, or company found guilty. Results from the remaining samples sent to national laboratories are still awaited, and their findings are expected to be critical to the final determination.
Point of View
But the GMC Kota clarification reveals the limits of headline-driven accountability: a failed quality test is not the same as a proven cause of death. Sepsis and MODS are multi-factorial outcomes, and attributing five deaths to a single injectable without autopsy and pharmacovigilance data is premature. What the case does expose, unmistakably, is a procurement and quality-control failure in a public hospital drug supply chain — and that alone warrants the full force of the Drugs and Cosmetics Act, regardless of what the final causal determination shows.
NationPress
11 Jul 2026
Frequently Asked Questions
Why did five women die at Government Medical College Kota?
Five women died following complications after cesarean section procedures at GMC Kota. Medical records and expert review indicate they suffered from Sepsis and Multi-Organ Dysfunction Syndrome (MODS), though the precise causal chain is still under investigation.
Was the Oxytocin injection responsible for the deaths?
One Oxytocin batch (TOCIN I-7881) has been declared 'Not of Standard Quality/Spurious', but GMC Kota has clarified that this alone is not scientifically proven to have caused the deaths. No conclusive clinical evidence linking Oxytocin directly to mortality has emerged so far.
What legal action has been taken in the Kota hospital deaths case?
Authorities have initiated legal proceedings under the Drugs and Cosmetics Act, 1940, which includes provisions for filing an FIR and imprisonment if guilt is established. The Drug Control Department has also launched a supply chain investigation.
How many medicine samples were tested and what were the results?
Of 28 samples collected, results for 23 have been received. All 23 passed quality standards except one — an Oxytocin injection with batch number TOCIN I-7881, which was declared spurious after failing a specific test parameter. Results from the remaining samples are still awaited.
What happens next in the Kota C-section deaths investigation?
The Rajasthan government has assured a thorough scientific investigation, with remaining sample results from national laboratories still pending. Strict action has been promised against any individual, institution, or company found guilty once the probe concludes.
